Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders. (Q47898060)

From Wikidata

Jump to navigation Jump to search

scientific article published on 26 June 2016

Language	Label	Description	Also known as
English	Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders.	scientific article published on 26 June 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9-Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

autism spectrum disorder

0 references

1 reference

based on heuristic

inferred from title

liquid chromatography-tandem mass spectrometry

1 reference

based on heuristic

inferred from title

author name string

Natchaya Vanwong

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Santirat Prommas

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Apichaya Puangpetch

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Yaowaluck Hongkaew

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Nopadol Nuntamool

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Chalitpol Na Nakorn

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Nattawat Ngamsamut

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Penkhae Limsila

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Chonlaphat Sukasem

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

publication date

26 June 2016

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Journal of Clinical Laboratory Analysis

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

30

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1236-1246

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Risperidone in children with autism and serious behavioral problems

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Clinical response to risperidone in relation to plasma drug concentrations in acutely exacerbated schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Impact of multiple inhibitors or substrates of cytochrome P450 2D6 on plasma risperidone levels in patients on polypharmacy

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

CYP2D6 genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort study

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Risperidone plasma levels, clinical response and side-effects

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Predictors of Risperidone and 9-Hydroxyrisperidone Serum Concentration in Children and Adolescents

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Risperidone in Schizophrenia: Is There a Role for Therapeutic Drug Monitoring?

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with various doses of risperidone

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in plasma after overdose

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdose

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detection

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MS.

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Determination of risperidone in human plasma by HPLC-MS/MS and its application to a pharmacokinetic study in Chinese volunteers

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Serum levels of risperidone and its metabolite, 9-hydroxyrisperidone: correlation between drug concentration and clinical response.

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Validated LC-MS/MS methods for the determination of risperidone and the enantiomers of 9-hydroxyrisperidone in human plasma and urine

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders

1 reference

https://api.crossref.org/works/10.1002%2FJCLA.22009

21 January 2018

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27346210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography: application to therapeutic drug monitoring in Japanese patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/27346210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical profile of risperidone, a new antipsychotic

1 reference

https://pubmed.ncbi.nlm.nih.gov/27346210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone

1 reference

https://pubmed.ncbi.nlm.nih.gov/27346210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reversed-phase liquid chromatography with ultraviolet detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/27346210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27346210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/JCLA.22009

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27346210%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47898060&oldid=2144963778"